0001756702-18-000001.txt : 20181024
0001756702-18-000001.hdr.sgml : 20181024
20181024143702
ACCESSION NUMBER: 0001756702-18-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
EFFECTIVENESS DATE: 20181024
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Castle Creek Pharmaceutical Holdings, Inc.
CENTRAL INDEX KEY: 0001756702
IRS NUMBER: 831984773
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-324223
FILM NUMBER: 181136218
BUSINESS ADDRESS:
STREET 1: 6 CENTURY DRIVE, 2ND FLOOR
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 847-715-0606
MAIL ADDRESS:
STREET 1: 6 CENTURY DRIVE, 2ND FLOOR
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
D
1
primary_doc.xml
X0708
D
LIVE
0001756702
Castle Creek Pharmaceutical Holdings, Inc.
6 CENTURY DRIVE, 2ND FLOOR
PARSIPPANY
NJ
NEW JERSEY
07054
847-715-0606
DELAWARE
None
None
Corporation
true
2018
Patrick
Morris
c/o Castle Creek Pharmaceutical Holdings
6 Century Drive, 2nd Floor
Parsippany
NJ
NEW JERSEY
07054
Executive Officer
Director
President, Secretary and Treasurer
Michael
Derby
c/o Castle Creek Pharmaceutical Holdings
6 Century Drive, 2nd Floor
Parsippany
NJ
NEW JERSEY
07054
Executive Officer
Director
Chief Executive Officer
Antonio
Gracias
c/o Castle Creek Pharmaceutical Holdings
6 Century Drive, 2nd Floor
Parsippany
NJ
NEW JERSEY
07054
Director
Timothy
Cunniff
c/o Castle Creek Pharmaceutical Holdings
6 Century Drive, 2nd Floor
Parsippany
NJ
NEW JERSEY
07054
Director
Jeffrey
Aronin
c/o Castle Creek Pharmaceutical Holdings
6 Century Drive, 2nd Floor
Parsippany
NJ
NEW JERSEY
07054
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2018-10-09
false
true
false
0
Octagon Capital Group, LLC
173341
None
None
45 Essex Street
Suite 204
Millburn
NJ
NEW JERSEY
07041
CT
CONNECTICUT
IL
ILLINOIS
MA
MASSACHUSETTS
NJ
NEW JERSEY
NY
NEW YORK
PA
PENNSYLVANIA
false
560544226
560544226
0
Total offering disclosed consists of: (a) shares of Series B Preferred Stock sold for $71,799,458 cash & (b) Series A Preferred Stock issued in exchange for membership interests in Castle Creek Pharmaceuticals, LLC, with an estimated value of $488,744,768
false
19
1217994
0
0
false
Castle Creek Pharmaceutical Holdings, Inc.
Patrick Morris
Patrick Morris
President
2018-10-23